Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Case Report 
RMJ. 2008; 33(1): 110-112


Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari.

Abstract
We report a 19 years old patient, at 32 weeks of gestation, with severe peripartum
cardiomyopathy, in heart failure and pulmonary edema. General anesthesia was
induced with etomidate and maintained with remifentanil infusion safely, without any
adverse outcome on mother or newborn. (Rawal Med J 2008;33:109-111).

Key words: Peripartum cardiomyopathy, cesarean section, etomidate, remifentanil, general anesthesia.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Eisa Bilehjani
Articles by Amir Abbas Kianfar
Articles by Mehrnoosh Solmaz Fakhari
on Google
on Google Scholar
Article Statistics
 Viewed: 5030
Downloaded: 806
Cited: 0


How to Cite this Article
Pubmed Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. RMJ. 2008; 33(1): 110-112.


Web Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. http://www.rmj.org.pk/?mno=7558 [Access: May 24, 2019].


AMA (American Medical Association) Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. RMJ. 2008; 33(1): 110-112.



Vancouver/ICMJE Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. RMJ. (2008), [cited May 24, 2019]; 33(1): 110-112.



Harvard Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari (2008) Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. RMJ, 33 (1), 110-112.



Turabian Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. 2008. Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. Rawal Medical Journal, 33 (1), 110-112.



Chicago Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. "Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy." Rawal Medical Journal 33 (2008), 110-112.



MLA (The Modern Language Association) Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari. "Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy." Rawal Medical Journal 33.1 (2008), 110-112. Print.



APA (American Psychological Association) Style

Eisa Bilehjani, Amir Abbas Kianfar, Mehrnoosh Solmaz Fakhari (2008) Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. Rawal Medical Journal, 33 (1), 110-112.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Scopus

  Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.